COMMITTEES
Home /
Committees
The PHRMAG Executive Committee (EC) comprises of experienced industry leaders that are committed to
providing strategic counsel, and serve as mentors for PHMRAG working groups. The PHRMAG EC plays a crucial
role in fostering collaboration, and driving our mission forward in the Gulf region.
Mazen Bachir
Chairman
General Manager Gulf and Emerging Markets EPD, Abbott
Sameh El Fangary
Vice-Chairman
Cluster President, AstraZeneca
Ashraf Mallak
Treasurer & EC Member
Managing Director GCC, MSD
Shahad Mahdi
Secretary General
PHRMAG
Mohamed Ezz Eldin
EC Member
Head Gulf Countries, Innovative Medicines, Novartis
Ahmed Abu El Fadl
EC Member
General Manager Gulf, Merck Serono
Pedro Matos Rosa
EC Member
General Manager, Johnson & Johnson Innovative Medicines Gulf
Diederik Kok
EC Member
Managing Director GCC, Biogen
Working Groups
The Working Groups at PHRMAG are dedicated to driving progress and excellence across geographies and in various key functional areas, These committees are strategically aligned with our mission and the needs of the healthcare ecosystems to help address important industry challenges, shape policies, and ensure compliance with ethical standards.
Kuwait
Lead: Amal Al Ali (AstraZeneca)
Mentor: Pedro Matos Rosa (Johnson & Johnson)
Regulatory
Lead: Ibrahim Nassar (Abbvie)
Mentor: Diedrick Kok (Biogen)
MOHAP/ DHA
Lead: Faisal Al Haji (Boehringer Ingelheim)
Mentor: Mohamed Ezz Eldin (Novartis)
DoH
Lead: Ghaleb Al Ahdab (AstraZeneca)
Mentor: Ashraf Mallak (MSD)
Healthcare Financing & Insurance
Lead: Yomna Nowier (Novartis)
Mentor: Pedro Matos Rosa (Johnson & Johnson)
Communications
Lead: Joy Khoury (Novartis)
IP Policy
Lead: Rania Ashraf (J&J)
Mentor: Ahmed Abou Fadl (Merck)
Qatar, Oman & Bahrain
Lead: Yasser Helmy (GSK)
Mentor: Sameh El Fangary (AstraZeneca)
Ethics & Compliance
Lead: Youssef Mourad (Roche)
Mentor: Mazen Bachir (Abbott)